|
PFDN5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.602200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.495800E-01 |
| Normal-vs-Stage2 |
4.762000E-01 |
| Normal-vs-Stage3 |
7.672000E-01 |
| Normal-vs-Stage4 |
6.232600E-01 |
| Stage1-vs-Stage2 |
3.491000E-01 |
| Stage1-vs-Stage3 |
4.962400E-01 |
| Stage1-vs-Stage4 |
7.865400E-01 |
| Stage2-vs-Stage3 |
6.092800E-01 |
| Stage2-vs-Stage4 |
3.149400E-01 |
| Stage3-vs-Stage4 |
4.921000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.213400E-01 |
| Normal-vs-AfricanAmerican |
6.557200E-01 |
| Normal-vs-Asian |
8.615800E-01 |
| Caucasian-vs-AfricanAmerican |
9.791400E-01 |
| Caucasian-vs-Asian |
7.725200E-01 |
| AfricanAmerican-vs-Asian |
8.252600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.489600E-01 |
| Normal-vs-Female |
7.345400E-01 |
| Male-vs-Female |
2.607000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.924600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.766600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.386200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.898600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.492000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.339800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.449800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.350400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.703400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.538800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.690300E-02 |
| Classical-VS-Follicular |
4.245500E-04 |
| Classical-VS-Other |
3.070000E-01 |
| Classical-VS-Normal |
2.597200E-01 |
| Tall-VS-Follicular |
4.32790000000072E-05 |
| Tall-VS-Other |
3.828400E-02 |
| Tall-VS-Normal |
3.056000E-02 |
| Follicular-VS-Other |
2.178500E-02 |
| Follicular-VS-Normal |
1.435540E-02 |
| Other-VS-Normal |
9.790600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.226400E-01 |
| Normal-vs-N1 |
5.525200E-01 |
| N0-vs-N1 |
1.549000E-01 |
|
|
